Undiagnosed COPD and Asthma Population Study (UCAP)

NACompletedINTERVENTIONAL
Enrollment

508

Participants

Timeline

Start Date

June 5, 2017

Primary Completion Date

January 9, 2024

Study Completion Date

January 9, 2024

Conditions
AsthmaCOPD
Interventions
DRUG

Treatment strategy using evidence-based guidelines for asthma or COPD

The respirologist will determine the clinical extent of the patient's symptoms, activity limitation, and degree of airflow obstruction and will commence the subject on asthma or COPD medications if indicated

BEHAVIORAL

Smoking Cessation

Smoking cessation counselling by a qualified educator if currently smoking

BEHAVIORAL

Participant Education

Standardized education for asthma or COPD disease

Trial Locations (15)

T2N 4N1

University of Calgary, Calgary

T6G 2C8

University of Alberta, Edmonton

V5Z 1M9

Vancouver General Hospital- The Lung Centre, Vancouver

R2H 2A6

St. Boniface General Hospital, Winnipeg

A1C 5B8

St. Clare's Mercy Hospital, St. John's

B3H 3A7

Queen Elizabeth II Health Sciences Centre, Halifax

L8N 4A6

Firestone Institute for Respiratory Health, Hamilton

K7L 2V7

Kingston General Hospital, Kingston

N6A 5W9

London Health Sciences Centre, London

K1H 8L6

The Ottawa Hospital-General Campus, Ottawa

M5B 1W8

St. Micheal's Hospital, Toronto

H3H 2R9

The Research Institute of the McGill University Health Centre (RI-MUHC), Montreal

H4J 1C5

Hopital du Scaré-Coeur, Montreal

G1V 4G5

IUCP, Hôpital Laval, Québec

S7N 0W8

University of Saskatchewan, Saskatoon

All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER